Chatellier G - Search Results

1

Effectiveness of exercise training on the dyspnoea of individuals with long COVID: A randomised controlled multicentre trial.

Romanet C, Wormser J, Fels A, Lucas P, Prudat C, Sacco E, Bruel C, Plantefève G, Pene F, Chatellier G, Philippart F. Romanet C, et al. Among authors: chatellier g. Ann Phys Rehabil Med. 2023 Jun;66(5):101765. doi: 10.1016/j.rehab.2023.101765. Epub 2023 Jun 2. Ann Phys Rehabil Med. 2023. PMID: 37271020 Free PMC article. Clinical Trial.

2

Association of Electrochemical Skin Conductance by Sudoscan and Cardiovascular Outcomes in Hemodialysis Patients.

Touzot M, Reach P, Mobio A, Sacco E, Fels A, Beaussier H, Ureña-Torres P, Chatellier G, Ridel C, Zuber M. Touzot M, et al. Among authors: chatellier g. Kidney Int Rep. 2022 Sep 16;7(12):2734-2736. doi: 10.1016/j.ekir.2022.09.013. eCollection 2022 Dec. Kidney Int Rep. 2022. PMID: 36506235 Free PMC article. No abstract available.

3

Effectiveness and reliability of the four-step STANDING algorithm performed by interns and senior emergency physicians for predicting central causes of vertigo.

Gerlier C, Fels A, Vitaux H, Mousset C, Perugini A, Chatellier G, Ganansia O. Gerlier C, et al. Among authors: chatellier g. Acad Emerg Med. 2023 May;30(5):487-500. doi: 10.1111/acem.14659. Epub 2023 Jan 30. Acad Emerg Med. 2023. PMID: 36628557 Free article.

4

Authors' reply to Sabour S. "The 4-step STANDING algorithm for predicting central causes of vertigo; methodological issues on reliability, validity, and prediction".

Gerlier C, Fels A, Chatellier G. Gerlier C, et al. Among authors: chatellier g. Acad Emerg Med. 2023 May;30(5):608-609. doi: 10.1111/acem.14676. Epub 2023 Feb 26. Acad Emerg Med. 2023. PMID: 36748126 Free article. No abstract available.

5

Effect of early ultrasound-guided femoral nerve block on preoperative opioid consumption in emergency patients with hip fracture: a randomized trial.

Gerlier C, Mijahed R, Fels A, Bekka S, Courseau R, Singh AL, Ganansia O, Chatellier G. Gerlier C, et al. Among authors: chatellier g. Eur J Emerg Med. 2024 Feb 1;31(1):18-28. doi: 10.1097/MEJ.0000000000001075. Epub 2023 Aug 24. Eur J Emerg Med. 2024. PMID: 37650732 Clinical Trial.

6

Systematic Review and Meta-analysis of Clinical Outcomes After Endovascular Treatment in Patients With Femoropopliteal Lesions Greater Than 150 mm.

Dubosq-Lebaz M, Fels A, Chatellier G, Gouëffic Y. Dubosq-Lebaz M, et al. Among authors: chatellier g. J Endovasc Ther. 2023 Sep 30:15266028231202709. doi: 10.1177/15266028231202709. Online ahead of print. J Endovasc Ther. 2023. PMID: 37776300 Review.

7

Amputation-free survival in the long-term follow-up and gender-related characteristics in patients revascularized for critical limb ischemia.

Lebreton O, Fels A, Compagnon A, Lazareth I, Ghaffari P, Chatellier G, Emmerich J, Michon-Pasturel U, Priollet P, Yannoutsos A. Lebreton O, et al. Among authors: chatellier g. J Med Vasc. 2023 Sep;48(3-4):105-115. doi: 10.1016/j.jdmv.2023.10.002. Epub 2023 Oct 17. J Med Vasc. 2023. PMID: 37914455

8

Doppler echocardiography for surveillance of acute cardiac allograft rejection: a 28-year single-center experience.

Vallée A, Houyel L, To NT, Fels A, Kloeckner M, Blanchard D, Lemann T, Gaillard M, Ramadan R, Genty T, Thomas de Montpreville V, Beaussier H, Chatellier G, Deleuze P, Haulon S, Guihaire J. Vallée A, et al. Among authors: chatellier g. Cardiovasc Diagn Ther. 2024 Feb 15;14(1):59-71. doi: 10.21037/cdt-23-305. Epub 2024 Jan 31. Cardiovasc Diagn Ther. 2024. PMID: 38434560 Free PMC article.

9

[Effects of a return-to -home assistance programm (PRADO-IC) on the patient journey in a cohort of cardiac heart failure patients].

Abassade P, Fleury L, Fels A, Chatellier G, Sacco E, Beaussier H, Komajda M, Cador R. Abassade P, et al. Among authors: chatellier g. Ann Cardiol Angeiol (Paris). 2024 Nov;73(5):101787. doi: 10.1016/j.ancard.2024.101787. Epub 2024 Sep 3. Ann Cardiol Angeiol (Paris). 2024. PMID: 39232335 French.

10

Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial.

Sapoval M, Thiounn N, Descazeaud A, Déan C, Ruffion A, Pagnoux G, Duarte RC, Robert G, Petitpierre F, Karsenty G, Vidal V, Murez T, Vernhet-Kovacsik H, de la Taille A, Kobeiter H, Mathieu R, Heautot JF, Droupy S, Frandon J, Barry Delongchamps N, Korb-Savoldelli V, Durand-Zaleski I, Pereira H, Chatellier G; PARTEM study group. Sapoval M, et al. Among authors: chatellier g. Lancet Reg Health Eur. 2023 Jun 26;31:100672. doi: 10.1016/j.lanepe.2023.100672. eCollection 2023 Aug. Lancet Reg Health Eur. 2023. PMID: 37415648 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters